These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


418 related items for PubMed ID: 18986690

  • 1. High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study.
    Thomas M, von Ziegenweidt J, Lee AJ, Price D.
    J Allergy Clin Immunol; 2009 Jan; 123(1):116-121.e10. PubMed ID: 18986690
    [Abstract] [Full Text] [Related]

  • 2. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM, Culler SD, Ershoff D, Gutierrez B.
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [Abstract] [Full Text] [Related]

  • 3. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM.
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [Abstract] [Full Text] [Related]

  • 4. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 5. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE, Hagiwara M, Stanford RH, Stempel DA.
    Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
    [Abstract] [Full Text] [Related]

  • 6. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC, Lau H, La HO, Choi IS, Geba GP.
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
    Gibson PG, Powell H, Ducharme FM.
    J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
    [Abstract] [Full Text] [Related]

  • 8. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
    Rowe BH, Wong E, Blitz S, Diner B, Mackey D, Ross S, Senthilselvan A.
    Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245
    [Abstract] [Full Text] [Related]

  • 9. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S, Vogelmeier C, Buhl R.
    Med Klin (Munich); 2008 May 15; 103(5):299-310. PubMed ID: 18484216
    [Abstract] [Full Text] [Related]

  • 10. Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA.
    Kiri VA, Bettoncelli G, Testi R, Viegi G.
    Respir Med; 2005 Sep 15; 99(9):1115-24. PubMed ID: 15921904
    [Abstract] [Full Text] [Related]

  • 11. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
    Eltonsy S, Forget A, Beauchesne MF, Blais L.
    J Allergy Clin Immunol; 2015 Jan 15; 135(1):123-30. PubMed ID: 25226849
    [Abstract] [Full Text] [Related]

  • 12. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
    Kiri VA, Fabbri LM, Davis KJ, Soriano JB.
    Respir Med; 2009 Jan 15; 103(1):85-90. PubMed ID: 18793832
    [Abstract] [Full Text] [Related]

  • 13. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug 15; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 14. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
    Ali AK, Hartzema AG, Winterstein AG, Segal R, Lu X, Hendeles L.
    Value Health; 2015 Mar 15; 18(2):260-70. PubMed ID: 25773561
    [Abstract] [Full Text] [Related]

  • 15. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
    Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G.
    Clin Ther; 2009 May 15; 31(5):1056-63. PubMed ID: 19539106
    [Abstract] [Full Text] [Related]

  • 16. Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists.
    Mapel DW, Hurley JS, Roblin D, Roberts M, Davis KJ, Schreiner R, Frost FJ.
    Respir Med; 2006 Apr 15; 100(4):595-609. PubMed ID: 16199151
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors.
    Ducharme FM, Noya FJ, Allen-Ramey FC, Maiese EM, Gingras J, Blais L.
    Curr Med Res Opin; 2012 Jan 15; 28(1):111-9. PubMed ID: 22077107
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.